Similar Articles |
|
Pharmaceutical Executive March 1, 2013 Ken Getz |
Building Clinical Trial Awareness for Patients: Why Not Try the Pharmacist? The author explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol. |
Pharmaceutical Executive February 1, 2007 John Smith |
Public Relations: Beef Up Clinical Trial Numbers Web-based public relations can make the difference in clinical-trial recruitment. |
Pharmaceutical Executive November 1, 2006 |
Unraveling the eSource Industry-wide standards for electronic patient data have long felt like buried treasure. Companies today are getting closer - by way of a tangled map. |
AFP eWire November 1, 2004 |
Assembly Approves Change to Ethical Code The Delegate Assembly approved a change in the AFP Code of Ethical Principles and Standards of Professional Practice that eliminates the distinction in the code between "charitable" funds raised and funds raised through advertising, sponsorships and other means. |
Chemistry World October 15, 2013 Dinsa Sachan |
Supreme court ruling brings clinical trials to a halt in India The fate of 162 global clinical trials hangs in the balance, as the top Indian court has asked the government to provide more details on their approval process before they can proceed. |
Bio-IT World April 16, 2004 Joel Hoffman |
Taking the Trial Out of Clinical Outsourcing Make sure the vendor's standard operating procedures will mesh with your own, and then tirelessly work toward systems integration. |
Chemistry World January 25, 2013 Rajesh Parishwad |
Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices. |
Bio-IT World January 21, 2005 |
How IT Can Decrease Time-to-Market in Clinical Trials Pharma manufacturers can learn from their industrial counterparts: Integrating systems can accelerate product delivery. |
Pharmaceutical Executive September 1, 2008 Melanie North |
Publish or Perish FDAAA means that companies need to register clinical trials; and not only for publication planning. |
Pharmaceutical Executive July 1, 2005 Ellen H. Julian |
What Pharma Wants From IT Today Indications that compliance and productivity issues reign over information technology (IT) budgets at pharma companies were verified in the 2005 Pharmaceutical Executive/Life Science Insights Information Technology Survey of nearly 850 US pharma companies. |
Job Journal May 2, 2010 Peggy Klaus |
Ethical Behavior in the Workplace Was the economic meltdown caused by illegal activities or immoral practices? Do we apply a different standard of ethics in the workplace than we expect from each other in our private lives? |
Bio-IT World January 21, 2005 John Otrompke |
Recruiting in the Workplace With hundreds of new therapeutic agents in the pipeline, it is no wonder that clinical trials sponsors are looking to organize trials around the workplace. |
Bio-IT World March 10, 2003 Dawn Stover |
E-Recruitment: Trial by Wire Online databases are helping patients find clinical trials -- but e-recruitment is no panacea for participant shortages. |
Bio-IT World May 9, 2003 Mark D. Uehling |
Data Rapture? Electronic capture of data: Some say it unclogs the medieval clinical trials process. Others remain skeptical of software and put their trust in paper. |
Pharmaceutical Executive October 1, 2005 Lisa Grimes |
Clear Road Ahead An industry standard for publicizing clinical-trial results is a ways off. But pharma's openness to more transparent procedures is moving things in the right direction. |
Chemistry World October 17, 2012 Maria Burke |
GSK pledge on trials transparency GlaxoSmithKline has announced a series of initiatives to make clinical trial data publically available that could set a precedent in an industry not known for its transparency. |
Pharmaceutical Executive January 1, 2011 Singh & Glozman |
Managing Clinical Trials in Emerging Markets Amgen's hub-and-spoke system combines control at home with the flexibility to respond to local needs. |
Pharmaceutical Executive May 1, 2009 |
Ad(Ventures) in Pharmaland Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration. |
National Defense March 2011 |
Statement of Defense Industry Ethics In November 2004, after several months of in-depth review the National Defense Industrial Association finalized and published its Code of Ethics. Five years later in 2009, NDIA undertook to review, and, in a small number of ways made minor but we believe worthy revisions. |
CFO March 15, 2006 Norm Alster |
I Am Joe's Conscience Employers are setting up ethics programs to teach workers to do the right thing. Is this the wrong approach? |
IEEE Spectrum June 2006 Carl Selinger |
Making Committees Work Volunteering for committees is a great way to get involved in businesses and in professional societies. You'll learn new skills and subjects and rub elbows with people you might not normally get a chance to work with. This can open the door to potential mentoring relationships and, yes, job offers. |
Pharmaceutical Executive November 1, 2012 Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
Entrepreneur October 2003 Joshua Kurlantzick |
Liar, Liar In the race to make money, some American businesses have been lying their pants off -- but is success at any cost really worth the price? |
Chemistry World November 12, 2013 Dinsa Sachan |
Rough patch for India's clinical trial industry The Indian clinical trial industry is beset by uncertainty. Campaigners have petitioned the courts claiming that drug companies are exploiting poor people and this has led to more than 100 trials being put on hold. |
Pharmaceutical Executive March 1, 2014 Jill Wechsler |
Data disclosure, integrity challenge pharma Transparency initiatives are multiplying, affecting research, marketing and compliance. |
Pharmaceutical Executive June 1, 2005 Doretta Gasorek |
Who Sees the Halo? Insiders say pharma ethics reputations shine. Consumers don't see the glow. |
National Defense November 2004 Joe Reeder |
Association Unveils New Ethics Code for Industry The National Defense Industrial Association's Ethics Committee has developed a benchmark statement of industry ethics for companies to incorporate into their day-to-day business. |
American Family Physician August 15, 2004 Lang & Quill |
Making Decisions with Families at the End of Life Because advance directives are not yet the norm, end-of-life decisions for patients without medical decision-making capacity are made regularly within discussions between the patient's physician and family. |
National Defense April 2015 Dave Melcher |
Understanding the Value of Ethics Surveys A healthy ethical culture is a critical component of all successful businesses, regardless of size or complexity. |
Foundation News & Commentary Jul/Aug 2005 Neen Hunt |
Funding Ethics Scholarship Advances in science and research are producing ethical and legal issues, as well as opportunities for philanthropy to help address them. |
Managed Care April 2002 MargaretAnn Cross |
Where Do No Harm Meets The Right Thing To Do Managed care's spread parallels the growth of the study of ethics in medical care. Ethicists help plans focus on essentials when making policy decisions... |
Managed Care July 2006 Michael S. Victoroff |
Guide to Critical Care Ethics Not Ready for Prime Time A potential useful volume on ethics in critical care falls short of expectations, often skimming the surface of important debates. |
National Defense August 2007 Brian Sears |
Building an Ethical Culture From the Top The NDIA ethics code encourages companies always to aspire to and implement best practices in all dealings with the government and other businesses. |
American Family Physician March 15, 2002 Frank A. Chervenak |
A Group Practice Disagrees About Offering Contraception This case concerns the justification of moral constraints that a physician group decides to apply to itself in the provision of patient services. Family physicians confront this issue with regard to reproductive medical services as well as other practices... |
Pharmaceutical Executive June 1, 2006 Cindy D'Aoust |
Who's Coming to Meetings? Need to attract the "right" physicians to a promotional meeting? Have to do it on a budget while following new compliance rules? Check out this new survey to see how the rest of pharma lives with a shifting promotional landscape. |
National Defense June 2015 Sandra Evers-Manly |
An Ethical Culture: Own it, Live it, Lead it Anyone involved in ethics and compliance within the defense industry should know that to be truly effective, a corporate ethics program requires more than a "check the box" approach |
AskMen.com Richard Stevens |
Participating In Clinical Trials Check out what participating in clinical trials involves and how you can join a study. You may even make some cash in the process. |
AFP eWire May 25, 2010 |
Imagine Canada Officially Endorses Donor Bill of Rights Earlier this year, the Imagine Canada board endorsed the Donor Bill of Rights as had been proposed by Imagine Canada's Ethical Code Committee. |
The Motley Fool June 17, 2010 Luke Timmerman |
Oncothyreon's Cancer Vaccine Back in the Saddle as Merck KGaA Re-Starts Clinical Trials The German-based Merck got clearance from the FDA and local ethics review boards to resume two of three large pivotal trials. |
Pharmaceutical Executive October 1, 2008 RS Kumar |
Evolving Clinical Trials Clinical trials need to change. A recent survey shows that industry should address the research supply chain for the greatest gains in efficiency. |
Information Today July 2, 2013 |
Thomson Reuters Offers Clinical Trial Intelligence Solutions These solutions improve clinical trials, speed up product development and release, and help professionals strengthen portfolios and R&D strategy. |
Chemistry World April 2006 Karen Harries-Rees |
Editorial: Drugs Testing on Trial A drugs trial in the UK that went disastrously wrong last month has raised questions about the ethics of using paid volunteers in clinical trials and the usefulness of animal testing. |
National Defense September 2015 Charles L. Szews |
Trust Plays Big Role in Corporate Culture In the defense industry, doing the right thing protects American lives and has national security implications. |
The Motley Fool May 23, 2007 Brian Orelli |
Pharma TV -- All Drugs, All the Time A combined media effort of four big pharmas in Europe sounds like a great idea, from an investor's perspective. But will it work? |
Managed Care February 2007 MargaretAnn Cross |
How Much Trouble Does Health Care Marketing Cause? Whether for drugs, imaging, surgery, or emergency services, direct-to-consumer advertising sparks lively debate. |
Inc. November 2004 Darren Dahl |
Do the Right Thing -- or Else New federal ethics rules apply to all companies, regardless of size. |
Bio-IT World June 2006 Mark D. Uehling |
Afferenz on EDC, Images, and Data Integration There are people who think the outsourcing of IT to India will not affect the life sciences. But companies like Afferenz raises concerns about U.S. companies lagging behind Indian companies on laying the foundation for clinical trials. |
AFP eWire August 21, 2006 |
New Survey Profiles Canadian Fundraisers A new survey of Canadian fundraisers shows that a large majority abides by a code of ethics, but only half have a Donor Bill of Rights in place as a formal measure in their organization. |
InternetNews November 13, 2007 Kenneth Corbin |
It's Not Your Father's Ad Industry IBM study predicts the rise of interactive advertising to stand the industry on its head. |
CIO June 16, 2010 Kim S. Nash |
Globalization: IT Tools to Collaborate and Bridge Language Gaps How BBK Worldwide uses graphics software to bridge language gaps and collaborate with doctors to recruit patients globally for clinical trials. |